Clinical trials
Phase 2 Primary Myelofibrosis trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2021 | 3 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 2 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| John Mascarenhas | 3 |
| Sierra Oncology LLC - a GSK company | 3 |
| GlaxoSmithKline | 2 |
| Incyte Corporation | 2 |
| AbbVie | 1 |
| Gemin X | 1 |
| Geron Corporation | 1 |
| Hoffmann-La Roche | 1 |
| Karyopharm Therapeutics Inc | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 17 |
| Myeloproliferative Disorders | 3 |
| Polycythemia Vera | 3 |
| Thrombocythemia, Essential | 2 |
| Anemia | 1 |
| Bronchiolitis Obliterans | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Fibrosis | 1 |
| Hematologic Diseases | 1 |
| Neoplasms | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.